Brief: PCI Biotech in pre-clinical research collaboration with large pharma company

PCI Biotech Holding ASA

10/09/2015 07:00

Sept 10 (Reuters) - PCI Biotech Holding  PCIB.OL : 
    * Announces clinical research collaboration agreement with a large pharma company 
    * Initial purpose is to determine whether PCI has potential to enhance therapeutic effect of 
their nucleic acid technology platform 
    * Companies will evaluate the data generated in collaboration and based on this explore the 
potential for a further partnership 
    * Original evaluation period spans over 9 months, but may be further extended 
 
     
Source text for Eikon:  ID:nHUG3TWssQ  
Further company coverage:  PCIB.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))